Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. India
  4. Bombay Stock Exchange
  5. Novartis India Limited
  6. Company
    500672   INE234A01025

NOVARTIS INDIA LIMITED

(500672)
  Report
End-of-day quote. End-of-day quote Bombay Stock Exchange - 10/14
795.55 INR   +0.91%
08/17NOVARTIS INDIA LIMITED : Ex-dividend day for final dividend
FA
08/12NOVARTIS INDIA : Net Profit Climbs in Fiscal Q1
MT
08/11Indian Indices End at Mixed Note on Wednesday; Tata Steel Jumps 4%
MT
SummaryChartsNewsCalendarCompanyFinancials 
Business Summary
Novartis India Limited manufactures drugs, medicines and allied products. The Company is engaged in the wholesale of pharmaceuticals and medical goods. The Company focuses on over three divisions, including pharmaceuticals, eye care and generic medicines. The Pharmaceuticals segment includes a portfolio of prescription medicines, which are provided to patients through healthcare professionals. Its Pharmaceutical business is focused on bone and pain, calcium portfolio, gynecology and neurosciences. The pharmaceuticals division is engaged in the development and commercialization in oncology, primary care and specialty medicines. The Generics segment comprises retail generics products. The business unit primarily focuses on the therapeutic segments, such as anti-tuberculosis (TB), anti-dysfunctional uterine bleeding (DUB (Gynecology)), antihistamines, antibiotics, anti-ulcerants, anti-diabetes and cardiovascular. The Company's geographical segments include India and Other Countries.

Number of employees : 539 people.
Sales per Business
2021
Pharmaceutical Products3 564.6093.5%
Commission157.404.1%
Services91.502.4%
INR in Million
Sales per region
20202021Delta
India4 382.50100%3 813.50100% -12.98%
INR in Million
Managers
Name Title Age Since
Sanjay Prabhakar Murdeshwar Vice Chairman & Managing Director 55 2019
Felix Doss Chief Financial Officer - 2019
Trivikram Guda Secretary & Compliance Officer - 2017
Jai Vishwanath Hiremath Independent Non-Executive Director 72 2006
Christopher Snook Non-Executive Chairman - 2008
Sandra Martyers Independent Non-Executive Director - 2016
Sanker Parameswaran Independent Non-Executive Director 61 2020
Bhavna Gupta Internal Auditor & Senior ERC Manager - 2020
Members of the board
Name Title Age Since
Christopher Snook Non-Executive Chairman - 2008
Jai Vishwanath Hiremath Independent Non-Executive Director 72 2006
Monaz Noble Non-Independent Non-Executive Director 54 -
Sandra Martyers Independent Non-Executive Director - 2016
Sanjay Prabhakar Murdeshwar Vice Chairman & Managing Director 55 2019
Sanker Parameswaran Independent Non-Executive Director 61 2020
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 24,690,797 6,749,056 27.3% 0 0.0% 27.3%
Shareholders
NameEquities%
Novartis AG 17,450,680 70.7%
Atul Ltd 374,627 1.52%
Government of India 116,434 0.47%
quant Money Managers Ltd. 30,632 0.12%
Allianz Global Investors GmbH 13,577 0.055%
Dimensional Fund Advisors LP 1,266 0.0051%
Dimensional Fund Advisors Ltd. 1,122 0.0045%
Company contact information
Novartis India Ltd.
Inspire-BKC, Part of 601 & 701
Bandra Kurla Complex
Bandra East
Mumbai, Maharashtra 400051

Phone : +91.22.5024.3000
Fax : +91.22.5024.3010
Web : http://www.novartis.in
Brand Portfolio
In partnership withAllbrands.markets
More brands of Novartis India Limited
Sector Other Pharmaceuticals
1st jan.Capi. (M$)
NOVARTIS INDIA LIMITED16.11%262
JOHNSON & JOHNSON2.49%424 619
ROCHE HOLDING AG16.59%339 442
NOVO NORDISK A/S54.22%234 792
PFIZER, INC.12.71%232 621
ELI LILLY AND COMPANY40.89%215 657
MERCK & CO., INC.-4.24%198 283
ABBVIE INC.2.03%193 205
ASTRAZENECA PLC20.08%187 492
NOVARTIS AG-8.03%186 330
BRISTOL-MYERS SQUIBB COMPANY-5.92%129 683
SANOFI6.53%122 086
AMGEN INC.-9.60%118 022
GLAXOSMITHKLINE PLC4.29%96 396
ALLERGAN PLC0.97%63 659
CHUGAI PHARMACEUTICAL CO., LTD.-27.49%57 462
BAYER AG-0.56%54 575
JIANGSU HENGRUI MEDICINE CO., LTD.-46.12%49 566
DAIICHI SANKYO COMPANY, LIMITED-16.76%49 400
TAKEDA PHARMACEUTICAL COMPANY LIMITED-13.93%44 517
ASTELLAS PHARMA INC.25.60%32 494